Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppression of DLBCL Progression by the E3 Ligase Trim35 Is Mediated by CLOCK Degradation and NK Cell Infiltration. | J Immunol Res | 2021 | 34124276 | PubTator, text mining | PubMed |
| An Immune-Related Long Non-Coding RNA Signature to Predict the Prognosis of Ewing's Sarcoma Based on a Machine Learning Iterative Lasso Regression. | Front Cell Dev Biol | 2021 | 34124041 | PubTator, text mining | PubMed |
| Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review. | Medicine (Baltimore) | 2021 | 34115047 | PubTator, text mining | PubMed |
| Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications. | Ther Adv Hematol | 2021 | 34104369 | PubTator, text mining | PubMed |
| Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers. | Transl Psychiatry | 2021 | 34103475 | PubTator, text mining | PubMed |
| Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes. | Acta Biomater | 2021 | 34102338 | PubTator, text mining | PubMed |
| Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy. | J Immunother Cancer | 2021 | 34083420 | PubTator, text mining | PubMed |
| Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib. | Onco Targets Ther | 2021 | 34079282 | PubTator, text mining | PubMed |
| A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. | Vaccines (Basel) | 2021 | 34070152 | PubTator, text mining | PubMed |
| Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art. | Vaccines (Basel) | 2021 | 34069321 | PubTator, text mining | PubMed |
| Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress. | Int J Mol Sci | 2021 | 34068052 | PubTator, text mining | PubMed |
| Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy. | Vaccines (Basel) | 2021 | 34063388 | PubTator, text mining | PubMed |
| Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. | Proc Natl Acad Sci U S A | 2021 | 34050029 | PubTator, text mining | PubMed |
| Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes. | Front Neurosci | 2021 | 34045940 | PubTator, text mining | PubMed |
| Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines. | Front Pharmacol | 2021 | 34040536 | PubTator, text mining | PubMed |
| Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. | Blood Cancer J | 2021 | 34039950 | PubTator, text mining | PubMed |
| Elevated Alu retroelement copy number among workers exposed to diesel engine exhaust. | Occup Environ Med | 2021 | 34039759 | PubTator, text mining | PubMed |
| IQGAP2 acts as an independent prognostic factor and is related to immunosuppression in DLBCL. | BMC Cancer | 2021 | 34034707 | PubTator, text mining | PubMed |
| The discriminatory power of the T cell receptor. | Elife | 2021 | 34030769 | PubTator, text mining | PubMed |
| Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions. | Front Chem | 2021 | 34017824 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=45